ENTECAVIR SANDOZ 0,5 MG TBL FLM 30

What is the maximum co-payment for ENTECAVIR SANDOZ?

If the insurance company contributes, the maximum co-payment is 3 510,57 Kč. The maximum pharmacy price is 11 707,48 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but check the specialization of the prescribing physician below (a so-called non-delegable prescription).

Does ENTECAVIR SANDOZ have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

8 196,91 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Entecavir o síle 0,5 mg je hrazen k časově omezené i dlouhodobé léčbě chronické hepatitidy B u dosud neléčených dospělých pacientů s kompenzovaným jaterním onemocněním, významnou replikací viru (hladina HBV DNA v séru vyšší než 2 000 IU/ml) a histologicky prokázaným aktivním zánětem a/nebo fibrózou. Z prostředků veřejného zdravotního pojištění je hrazena dávka maximálně 0,5 mg denně.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe ENTECAVIR SANDOZ?

infectious diseases medicine
gastroenterology, pediatric gastroenterology and hepatology

What is the composition of ENTECAVIR SANDOZ?

Monohydrát entekaviru (0,5325 mg), entekavir (0,5 mg), monohydrát laktosy, neznámá látka s kódem 3755, neznámá látka s kódem 17840, magnesium-stearát, hypromelosa 2910, makrogol 6000, oxid titaničitý, ointmentek. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to ENTECAVIR SANDOZ?

The medicine belongs to ATC group J05AF10 – ENTEKAVIR. Medicines with the same active substance can be found here.

Who manufactures ENTECAVIR SANDOZ?

Informace o výrobci není dostupná.

Is the medicine in shortage?

The latest report from the manufacturer is from 23. 1. 2025. Production was terminated with effect from 31. 1. 2025. The manufacturer lists medicines with the following code as a potential substitute: